Skip to main content
Clinical Trials/CTRI/2024/03/064569
CTRI/2024/03/064569
Not yet recruiting
Phase 2

A Comparative Study To Evaluate The Efficacy Of Phalatrikadi Churna Along With Dietery Modification And Musta Churna In The Management Of Medodushti (Dyslipidemia) A Randomized Controlled Open Label Clinical Trial - Nil

All India Institute Of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Sponsor
All India Institute Of Ayurveda
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients Between The Age Group Of 21\-60 Years Of Either Sex.
  • 2\)BMI Greater Than 25 Kg Per M2
  • 3\)Willing And Able To Participate In The Study For 1month.
  • 4\) Patients Having Abnormal Lipid Profile Eg T.Cholesterol Greater Than 200 And T.Cho/HDL Greater Than 4\.5\.
  • 5\)Patients With Strictly Controlled Diabetes Mellitus (Hba1c Less Than Or Equal To 6\.5 Percent).
  • 6\)Patient With Pratyatma Lakshan Of Medodushti.

Exclusion Criteria

  • 1\)Patients With Poorly Controlled Diabetes Mellitus (Hba1c Greater Than 6\.5Percent) And Hypertension (BP Greater Than 160 By 100 Mm Hg.
  • 2\)Pregnant Or Lactating Woman.
  • 3\)BMI Less Than 40kg Per M2
  • 4\)Patients With Genetic Syndromes, Severe Cardiovascular Disease Or Any Other Life\-Threatening Condition.
  • 5\)History Of Hypersensitivity To Any Of The Trial Drugs Or Their Ingredients.
  • 6\)Patients Having Systemic Illness Which Will Interfere With The Course Of Procedure.
  • 7\)Patients Who Are Already Enrolled In Other Study.

Outcomes

Primary Outcomes

Not specified

Similar Trials